These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9388984)

  • 1. [Frontier of gene engineering: gene prevention of diseases].
    Zhang D; Gao B; Zhu G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Aug; 18(4):312-4. PubMed ID: 9388984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
    Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
    Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existing antiviral vaccines.
    Ravanfar P; Satyaprakash A; Creed R; Mendoza N
    Dermatol Ther; 2009; 22(2):110-28. PubMed ID: 19335723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations.
    Wu JJ; Huang DB; Pang KR; Tyring SK
    J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vaccination of dogs with recombinant rabies virus vaccines.
    Rupprecht CE; Hanlon CA; Blanton J; Manangan J; Morrill P; Murphy S; Niezgoda M; Orciari LA; Schumacher CL; Dietzschold B
    Virus Res; 2005 Jul; 111(1):101-5. PubMed ID: 15896409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
    Rebedea I; Diaconescu IG; Bach D; Bartelsen O; Arndtz N
    Vaccine; 2006 Jun; 24(25):5320-6. PubMed ID: 16707195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release potency tests of hepatitis vaccines.
    Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M
    Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the afficacy of hepatitis B immunization among youngsters in Beijing].
    Gong XH; Li YH; Liu LR; Jia L; Xing YL; Wang YQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):388-90. PubMed ID: 15231158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
    NAM JH; BANG HS; CHO HW; CHUNG YH
    Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of gene-based vaccines.
    Barouch DH
    J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].
    Li P; Hu Q; Sun Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):170-4. PubMed ID: 12569788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The core antigen of hepatitis B virus as a carrier for immunogenic peptides.
    Murray K; Shiau AL
    Biol Chem; 1999 Mar; 380(3):277-83. PubMed ID: 10223329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low response to hepatitis B virus vaccine in Costa Rican health-care workers.
    Taylor L; García Z; Herrera G; Luftig RB; Visona KA
    Hepatology; 1998 Feb; 27(2):637. PubMed ID: 9462669
    [No Abstract]   [Full Text] [Related]  

  • 17. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
    Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
    J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.